![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Optibiotix Health Plc | LSE:OPTI | London | Ordinary Share | GB00BP0RTP38 | ORD 2P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.25 | 1.59% | 16.00 | 15.50 | 16.50 | 16.00 | 15.75 | 15.75 | 282,805 | 08:09:01 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Noncomml Resh Organizations | 457k | 2.59M | 0.0284 | 5.63 | 14.59M |
Date | Subject | Author | Discuss |
---|---|---|---|
24/1/2017 09:17 | Well appears fincap the house broker have kept the lid on this and are constantly on the offer. Have to fill the ii orders somehow. I'm a buyer at this false retrace. You can see the small panicked sells being mopped up. Sm | ![]() shrewdmole | |
24/1/2017 09:15 | Ah, I read it differently, but now you've explained - thank you ;0) | ![]() spike_1 | |
24/1/2017 09:15 | Insider trading comes with a prison sentence. I have tried to help you all ,but just get the Mickey taken out of me. Best of luck to you all. DIAMOND | ![]() diamond fibre | |
24/1/2017 08:47 | Nothing odd about it whatsoever. We are struggling to crack 80p. It hits it and then drops back. Be good to see the back of 80p for good. For ever Whats odd about that spike? | ![]() judijudi | |
24/1/2017 08:44 | JJ: 'for good' odd comment? ;0) Best wishes - Mike | ![]() spike_1 | |
24/1/2017 08:14 | thx Someuwin... I must check the website more often, now that Opti are obviously up and running on the marketing front. GLA LTHs and new... very exiting times ahead! | ![]() nicktopten | |
24/1/2017 08:05 | Interesting to see the mention of cancers here... | ![]() someuwin | |
24/1/2017 07:55 | As we have cutting edge technology it is important that we "shout about" our work, and these congresses give us the perfect platform and opportunity to do so.We have the Berlin one and the associated publications to look forward to just next week! | ![]() parob | |
24/1/2017 07:55 | Spike, This is our year imho | ![]() judijudi | |
24/1/2017 07:47 | Optibiotix at the forefront of a £46b market? Therein lies the value! Pick a number? | ![]() smarner | |
24/1/2017 07:42 | JJ: Well the last year of 'near term' has - if we believe the frustration shown on these pages - not been 'of no consequence' to most here. Putting near term value into the company is what most of us would like just for starters! Parob - yes an interesting 'development' which should have value! Best wishes - Mike | ![]() spike_1 | |
24/1/2017 07:38 | Great to hear we're getting more and more global exposure placing us at the forefront of global microbiome research and product development.The fact that we can enhance the growth and health benefits of existing probiotic products already on the market, surely means a faster route to commercialisation. | ![]() parob | |
24/1/2017 07:32 | Spike, If your an investor, near term has no consequence. Commercial success of the products over time has imho | ![]() judijudi | |
24/1/2017 07:23 | Difficult to know quite how important this is. The good news is that they have clearly done trials on a number of species/strands, and will be able to demonstrate they have taken them to the point where they are robust enough and cheap enough to be commercially viable. Unfortunately - as usual - it is difficult to put a commercial value on it in the near term? Best wishes - Mike | ![]() spike_1 | |
24/1/2017 07:17 | Interesting :) | ![]() judijudi | |
24/1/2017 07:09 | RNS Number : 8917U OptiBiotix Health PLC 24 January 2017 OptiBiotix Health plc ("OptiBiotix" or the "Company") Presentation of research at Microbiome R&D and Business Collaboration: Asia OptiBiotix Health plc (AIM: OPTI), a life sciences business developing compounds to tackle obesity, high cholesterol, diabetes and skin care, announces that it will be presenting research data on its microbiome modulators at the Microbiome R&D and Business Collaboration Congress: Asia, in Hong Kong on the 1-2 March 2017. The conference brings together experts in all areas of microbiome research and is recognised around the world as one of theleading conferences for bringing together pharma, biotech, academic institutions and investors who are looking to develop and progress ground-breaking microbiome research into next generation products through partnering. OptiBiotix's conference abstract and presentation covers research which demonstrates the company's ability to create designer ingredients which can modify an individual's microbiome. These studies suggest commercial potential for:- i. The development of species or genera specific prebiotics which can selectively enhance the growth and health benefits of existing probiotic products. This new product concept, called an OptiBiotic®, has the potential to enhance probiotic health benefits and provide product differentiation in the probiotic market, a market forecast to be worth more than $46.5bn by 2020 (Markets and Markets). ii. Designer ingredients which can modify an individual's current microbiome to improve health. These ingredients are heat resistant and stable during processing, which creates the opportunity to incorporate low cost, safe, ingredients which modulate specific elements of the microbiome in a wide range of food products. Commenting, Stephen O'Hara, CEO of OptiBiotix said: "The ability to create designer ingredients which can modify an individual's microbiome to improve health places OptiBiotix at the forefront of global microbiome research and product development. I believe we are fast approaching the next stage in the development of the microbiome in healthcare, where scientists have the ability to precision engineer components of the microbiome to prevent, manage and treat many of today's chronic lifestyle diseases." | ![]() someuwin | |
23/1/2017 20:59 | British Bulls signal: Signal Update Our system’s recommendation today is to STAY LONG. The previous BUY signal was issued on 06/01/2017, 17 days ago, when the stock price was 62.5723. Since then OPTI.L has risen by +25.06%. Market Outlook The bulls are in full control. The negative sentiment that led to the last bearish pattern has evaporated. Besides, the signal is suggesting to STAY LONG. It is best to follow the signal and continue to hold this security. | ![]() parob | |
23/1/2017 19:54 | Wow, just logged on! Fantastic. Few pennies a day will do me nicely. Good luck all | joyjoy13 | |
23/1/2017 19:33 | A little birdy told me Max and his GoFigure team invade Iceland tomorrow armed with goodies for their largest pharma outlets where there will be hands-on promo tour. That little birdies was me...yes, I speak to myself in the mirror. Joking apart, it's true. | elrico | |
23/1/2017 19:32 | Owen, Pure genius! :) | ![]() judijudi | |
23/1/2017 19:30 | My sentiments too Judi. | owenmo | |
23/1/2017 19:24 | Rocket Science from Diamond Great news coming and some exciting announcements Never!!! :) | ![]() judijudi | |
23/1/2017 19:18 | Diamond, based on your post I hope you haven't bought any shares today... | ![]() 1bokke |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions